Lucy Therapeutics, Inc. — Form D

Lucy Therapeutics, Inc. of Waltham, MA, a company, filed a Form D exempt-offering notice with the SEC on 2023-12-26. The offering totals $9.0M, of which $3.4M was reported sold. Industry: Pharmaceuticals.

Offering

Filed: 2023-12-26
Form: D
Accession: 0001782250-23-000002
Industry: Pharmaceuticals
Exemptions: 06b
Total offering: $9.0M
Amount sold: $3.4M
Remaining: $5.6M
Investors: 3
Date of first sale: 2023-12-15
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-500678

Issuer

Name: Lucy Therapeutics, Inc.
CIK: 0001782250
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2017
Address: 21 Hickory Drive, Suite 2B, Waltham, MA, 02451
Phone: 617-249-4812

Officers, directors & promoters (7)

Name	Role	Location
Ann DeWitt	Director	Woburn, MA
Rachel Sha	Director	Woburn, MA
Robert Michael Poole	Director	Waltham, MA
Amy Ripka	Director	Waltham, MA
Amy Ripka	Executive Officer	Waltham, MA
John Ripple	Director	Waltham, MA
Karoly Nikolich	Director	Cambridge, MA

Other filings by this issuer (4)

Filed	Form	Offering	Sold
2024-05-02	D/A	$10.6M	$10.6M
2022-01-06	D	$20.0M	$15.0M
2020-07-22	D/A	$4.5M	$3.0M
2019-07-15	D	$3.5M	$2.9M

More